drug

Gene testing could have saved weight-loss drug (Reuters)

Reuters – Genetic testing might have helped identify people who would become depressed or suicidal while taking Sanofi-Aventis’ weight loss drug Acomplia, which might have helped keep the drug on the market, U.S. researchers said on Thursday.

Read more from the original source:
Gene testing could have saved weight-loss drug
(Reuters)

drug

U.S. advisers reject Vivus’ fat pill (Reuters)

Reuters – The first new prescription weight-loss pill in more than a decade failed to win backing from U.S. health advisers, who said safety concerns about the drug outweighed its ability to help obese patients shed pounds.

See original here: 
U.S. advisers reject Vivus’ fat pill
(Reuters)

drug

FDA panel rejects experimental weight loss pill (AP)

AP – A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug’s side effects outweigh its ability to help patients lose weight.

Go here to read the rest: 
FDA panel rejects experimental weight loss pill
(AP)

drug

Vivus’ fat pill works but safety a concern: FDA staff (Reuters)

Reuters – Vivus Inc’s experimental obesity pill appears to help people shed pounds, but concerns remain about its safety, U.S. Food and Drug Administration staff said in documents made public on Tuesday ahead of a public meeting on the drug later this week.

Originally posted here: 
Vivus’ fat pill works but safety a concern: FDA staff
(Reuters)

« Previous Page